Chardan Healthcare Acquisition Corp. (CHAC) financial statements (2021 and earlier)

Company profile

Business Address 17 STATE STREET, 16TH FLOOR
NEW YORK, NY 10004
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
6/30/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments56821
Cash and cash equivalents36721
Short-term investments2010 
Restricted cash and investments 0 
Receivables 0 
Prepaid expense  0
Other current assets42 
Other undisclosed current assets1  
Total current assets:61851
Noncurrent Assets
Operating lease, right-of-use asset41
Property, plant and equipment22 
Long-term investments and receivables  71
Long-term investments  71
Deposits noncurrent assets 0 
Other undisclosed noncurrent assets350
Total noncurrent assets:10871
TOTAL ASSETS:709272
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities230
Accounts payable23 
Taxes payable  0
Debt10 
Other liabilities43 
Other undisclosed current liabilities  0
Total current liabilities:760
Noncurrent Liabilities
Long-term debt and lease obligation, including:51 
Other undisclosed long-term debt and lease obligation51 
Liabilities, other than long-term debt111
Due to related parties  1
Business combination, contingent consideration, liability11 
Total noncurrent liabilities:611
Total liabilities:1381
Temporary equity, carrying amount  66
Stockholders' equity
Stockholders' equity attributable to parent57845
Common stock000
Additional paid in capital1301275
Accumulated other comprehensive loss(72)(42) 
Retained earnings  0
Total stockholders' equity:57845
TOTAL LIABILITIES AND EQUITY:709272

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
6/30/2019
Revenues
(Net Investment Income)
11 
Cost of revenue
(Cost of Goods and Services Sold)
(0)  
Gross profit:11 
Operating expenses(30)(22)(0)
Other undisclosed operating loss(1)(1) 
Operating loss:(30)(22)(0)
Nonoperating income
(Investment Income, Nonoperating)
02 
Other undisclosed income from continuing operations before equity method investments, income taxes  1
Income (loss) from continuing operations before income taxes:(30)(21)0
Income tax expense (2)(0)
Income (loss) before gain (loss) on sale of properties:(30)(23)0
Other undisclosed net income 2 
Net income (loss) attributable to parent:(30)(21)0
Other undisclosed net income available to common stockholders, basic 41 
Net income (loss) available to common stockholders, diluted:(30)210

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
6/30/2019
Net income (loss):(30)(21)0
Comprehensive income (loss), net of tax, attributable to parent:(30)(21)0

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: